ClinicalTrials.Veeva

Menu

The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Interstitial Cystitis

Treatments

Drug: Hyaluronic Acid and Chondroitin Sulfate

Study type

Interventional

Funder types

Other

Identifiers

NCT03463499
2017-08-106

Details and patient eligibility

About

The efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate after transurethral resection of Hunner lesion in interstitial cystitis/bladder pain syndrome patients. To analyze the number and timing of recurrence based on a long-term follow-up.

Enrollment

62 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male and female aged 20 yrs or greater
  2. Patients diagnosed with Hunner lesion in IC(interstitial cystitis)/BPS(Bladder Pain Syndrome) and who is scheduled to undergo transurethral resection
  3. Symptom persisted more than 6 months
  4. Pain VAS ≥4

Exclusion criteria

  1. History of augmentation cystoplasty or previous transurethral coagulation/resection due to IC/BPS
  2. Child-bearing potential, pregnant or nursing women.
  3. Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
  4. Urinary tract infection during run-in periods.
  5. Genitourinary tuberculosis or bladder,urethral and prostate cancer
  6. Recurrent urinary tract infection
  7. History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate operation or treatment etc within 6months.
  8. Neurologic disease history of cerebral infarction,multiple sclerosis or parkinsonism etc.-
  9. Using a indwelling catheter or execution of intermittent self catheterization

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

62 participants in 1 patient group

Hyaluronic Acid and Chondroitin Sulfate
Experimental group
Description:
Intravesical instillation of Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients.
Treatment:
Drug: Hyaluronic Acid and Chondroitin Sulfate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems